Antipsychotic Polypharmacy for the Management of Schizophrenia: Evidence and Recommendations

Schizophrenia is a debilitating illness with a lifetime prevalence estimate of 0.6% and consists of symptoms from the positive, negative, and cognitive domains. Social support, therapy, psychoeducation, and overall case management are very important aspects of the treatment of schizophrenia. However...

Descripción completa

Detalles Bibliográficos
Autores principales: Lähteenvuo, Markku, Tiihonen, Jari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318953/
https://www.ncbi.nlm.nih.gov/pubmed/34196945
http://dx.doi.org/10.1007/s40265-021-01556-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318953/
https://www.ncbi.nlm.nih.gov/pubmed/34196945
http://dx.doi.org/10.1007/s40265-021-01556-4

Ejemplares similares